trending Market Intelligence /marketintelligence/en/news-insights/trending/um2lCe-wmZdbKkKhg4FuAg2 content esgSubNav
In This List

Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

Innovus Pharmaceuticals Inc. is implementing a 1-for-105 reverse split of its common stock.

The San Diego-based pharmaceutical company said its stock will begin trading on a split-adjusted basis on the OTCQB marketplace at the opening of trading March 18.

The reverse stock split was approved by a majority of Innovus' stockholders Feb. 22.